Skip to main content

Search

Subscribe To Our Newsletter

Join Our Contact Registry

Our Research
Patients & Families
Researchers & Clinicians
- Collaborate With Us
- Funding Opportunities
- Other Rare Disease Initiatives
- Resources for Researchers and Clinicians
- Data Sharing and Standards
  - Data Standards
  - DMCC Sharing Resources
Early Stage Investigators
News & Events
DMCC
About Us

Spotlight on Rare Diseases

The Newsletter of the National Institutes of Health-funded Rare Diseases Clinical Research Network

In this Issue:
Artificial Intelligence-Powered Telemedicine Tool Automates Scoring of Neuromuscular Examinations in Myasthenia Gravis Rare Research Report October 2024 Go to Issue

Newsletter of the Rare Diseases Clinical Research Network

Spotlight on Rare Diseases is the official newsletter of the Rare Diseases Clinical Research Network, an NIH-funded research network of 20 active consortia or research groups -- teams of researchers, patients, and clinicians -- each focused on a group of rare disorders. Look to this newsletter for news, features, and insights about rare diseases research from across our national network. Questions? Contact us at rd.dmcc@cchmc.org.

Go to Issue:

Archived Issues

Spotlight on Rare Diseases Newsletter Editor

Dakota Campbell
RDCRN Communications Program Manager

Join Our Email list

Footer menu

Contact Us
Website Policies
Rare Diseases Clinical Research Network
Genetic and Rare Diseases Information Center

social media

The Rare Diseases Clinical Research Network (RDCRN) is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). The RDCRN websites are hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818. The content of this website is the responsibility of the DMCC and the RDCRN consortia and does not necessarily represent the official views of the NIH.